Swiss All Share Index

Swiss All Share Index handeln
17.404,67 PKT -111,16 PKT -0,63 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
09.01.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
06.01.12 UBS overweight J.P. Morgan Cazenove
06.01.12 UBS overweight J.P. Morgan Cazenove
06.01.12 UBS outperform RBC Capital Markets
06.01.12 UBS buy Nomura
06.01.12 UBS neutral Nomura
06.01.12 SGS SA hold Société Générale Group S.A. (SG)
05.01.12 Novartis overweight J.P. Morgan Cazenove
05.01.12 Holcim neutral Credit Suisse Group
05.01.12 Swatch (I) buy Sarasin Research
04.01.12 ABB (Asea Brown Boveri) buy Deutsche Bank AG
04.01.12 Givaudan sell Deutsche Bank AG
04.01.12 UBS hold Deutsche Bank AG
04.01.12 UBS hold Deutsche Bank AG
04.01.12 Novartis buy Deutsche Bank AG
03.01.12 Holcim neutral Goldman Sachs Group Inc.
03.01.12 Adecco SA buy Vontobel Research
27.12.11 Novartis kaufen Raiffeisen Centrobank AG
27.12.11 Swisscom hold Vontobel Research
23.12.11 ABB (Asea Brown Boveri) neutral Sarasin Research
23.12.11 Novartis neutral Goldman Sachs Group Inc.
23.12.11 ABB (Asea Brown Boveri) buy Vontobel Research
22.12.11 Holcim hold Deutsche Bank AG
22.12.11 ABB (Asea Brown Boveri) outperform Exane-BNP Paribas SA
22.12.11 Holcim hold Deutsche Bank AG
22.12.11 BB Biotech halten Hamburger Sparkasse AG (Haspa)
22.12.11 ABB (Asea Brown Boveri) outperform Sanford C. Bernstein and Co., Inc.
21.12.11 UBS neutral Credit Suisse Group
21.12.11 Novartis overweight J.P. Morgan Cazenove
21.12.11 Richemont buy Nomura
21.12.11 Swatch (I) buy Nomura
21.12.11 Novartis hold Vontobel Research
21.12.11 Swatch (I) buy Société Générale Group S.A. (SG)
20.12.11 Swatch (I) buy Vontobel Research
20.12.11 SGS SA buy Vontobel Research
19.12.11 Holcim hold Deutsche Bank AG
19.12.11 Holcim hold Deutsche Bank AG
19.12.11 Zurich Insurance buy Nomura
16.12.11 Novartis outperform Credit Suisse Group
16.12.11 Swiss Re overweight J.P. Morgan Cazenove